ADMINISTRATIVE POLICY AND PROCEDURE

Similar documents
MEDICAL POLICY No R4 NEUROPSYCHOLOGICAL AND PSYCHOLOGICAL TESTING

Admission Criteria Continued Stay Criteria Discharge Criteria. All of the following must be met: 1. Member continues to meet all admission criteria

Neuropsychological Testing (NPT)

ADMINISTRATIVE POLICY AND PROCEDURE

Applied Behavior Analysis Therapy for Treatment of Autism Spectrum Disorder

Applied Behavior Analysis for Autism Spectrum Disorders

No An act relating to health insurance coverage for early childhood developmental disorders, including autism spectrum disorders. (S.

Applied Behavior Analysis Therapy for Treatment of Autism Spectrum Disorder

Medicare Part C Medical Coverage Policy

MEDICAL POLICY SUBJECT: PSYCHOLOGICAL TESTING. POLICY NUMBER: CATEGORY: Behavioral Health

Empire BlueCross BlueShield Professional Commercial Reimbursement Policy

MEDICAL POLICY Children's Intensive Behavioral Service/ Applied Behavioral Analysis (ABA)

Michigan Department of Health and Human Services (MDHHS) Behavioral Health and Developmental Disabilities Administration

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing

Applied Behavior Analysis Medical Necessity Guidelines

MEDICAL POLICY MEDICAL POLICY DETAILS POLICY STATEMENT POLICY GUIDELINES. Page: 1 of 5

Pediatric Neurodevelopmental and Autism Spectrum Disorder (ASD) Screening Corporate Medical Policy

AUTISM CLINICS DIAGNOSIS

Medical Necessity Guidelines: Applied Behavioral Analysis (ABA) including Early Intervention for RITogether

PUBLICATIONS SYSTEM CHANGE TRANSMITTAL FOR TRICARE POLICY MANUAL (TPM), AUGUST 2002

Medical Policy Original Effective Date: Revised Date: Page 1 of 6

FORM 3: ATTENTION DEFICIT/HYPERACTIVITY DISORDER VERIFICATION

KANSAS MEDICAL ASSISTANCE PROGRAM. Fee-for-Service Provider Manual. Rehabilitative Therapy Services

Psychological & Neuropsychological Test

SB365: Autism Health Insurance Reform

MEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS

BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Accessibility and Disability Service. A Guide to Services for Students with

Approved by: Integrated Health Quality Management Subcommittee Effective Date: Department of Origin: Integrated Healthcare Services.

Docket No CMH Decision and Order

Autism Services Overview. L. Logan, Texas Council for Developmental Disabilities

CT Behavioral Health Partnership. Autism Spectrum Disorder (ASD) Level of Care Guidelines

Establishing the Link: Assessment and Intervention of Children and Adults October 23, 2018

Mental & Behavioral Health Screening Updates Tips, tools, and reimbursement guidance

03/14/17. II. Initial early intensive-level behavioral and developmental therapy must have both of the following: A and B

Medicaid Coverage for Autism Spectrum Disorders (ASD) Treatment

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM

Basic Standards for Residency Training in General Neurology

Factors related to neuropsychological deficits in ADHD children

Small Group. SG_Ren_

MEDICAL POLICY SUBJECT: APPLIED BEHAVIOR ANALYSIS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDERS

Journey into Early Steps & CMS Network. Phyllis Sloyer, RN, PhD Division Director Children s Medical Services Department of Health

Behavioral Health Clinician in Primary Care Billing & Coding Guidance (Created September 2017)

Performance Indicator Trending Report

Medical Necessity Criteria

CALIFORNIA COUNTIES TREATMENT RECORD REQUIREMENTS

INAS ATHLETE ELIGIBILITY APPLICATION GUIDANCE NOTES VERSION: JUNE 2017

IEHP UM Subcommittee Approved Authorization Guideline Guideline Intravenous Sedation and General Guideline # UM_DEN 01. Date

LAKESHORE REGIONAL Entity Applied Behavior Analysis (ABA)

Chapter 7 Section Applied Behavior Analysis (ABA) For Non- Active Duty Family Members (NADFMs) Who Participate In The ABA Pilot

MEDICAL POLICY No R9 DETOXIFICATION I. POLICY/CRITERIA

Click to edit Master title style

Clinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: CP. PPA.03. Line of Business: Medicaid

Clinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: CP.PMN.121 Effective Date: Last Review Date: Line of Business: Medicaid

Autism-Related Services in North Carolina

Clinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: NH.PMN.36 Effective Date: Last Review Date: Line of Business: Medicaid

ATTENTION DEFICIT DISORDER; AEROMEDICAL CONSIDERATIONS

01/26/17. Replaces Effective Policy Dated: Autism Spectrum Disorders in Children: Assessment 01/19/16 and Evaluation Reference #: MP/A005 Page 1 of 4

Handbook for Postdoctoral Fellows at The Menninger Clinic

OFFICE OF MENTAL HEALTH AND SUBSTANCE ABUSE SERVICES BULLETIN

Children and Adults with Attention-Deficit/Hyperactivity Disorder Public Policy Agenda for Adults

Ohio. SAMPLE NCCI Edits*** Navigate to the Overall Coding Sheet

PSYCHOTROPIC MEDICATION UTILIZATION PARAMETERS FOR CHILDREN AND YOUTH IN FOSTER CARE

All Children s Health Insurance Program and Mental Health Providers. Subject: Coverage of Mental Health Codes for Children s Health Insurance Program

Autism Insurance Reform in Vermont. Judith Ursitti, CPA Director, State Government Affairs Autism Speaks

Pre-Employment Psychological Evaluation Guidelines

Meeting the Needs of the Adult Congenital Heart Disease Patient. Disclosures. Background. Background 6/3/2015. I have no relevant financial

FACT SHEET Mental Health and Substance Use Disorder Benefits

Psychological Testing

Page 1 of 11. Effective 9/15/2018 AUTHORIZATION REQUIREMENT LEVEL OF CARE. Notes (0 = No Additional Comments)

The Components of an Objective IME

3/5/2018. Advocating for Services in Early Childhood

P.O. Box 192, 119 Mill Rd.

Pediatric Primary Care Mental Health Specialist Certification Exam. Detailed Content Outline

STATE OF WEST VIRGINIA

Clinical Policy: Multiple Sleep Latency Testing

On April 4, Alaskan Youth Were in Out of State Residential Psychiatric Treatment

Clinical Policy: Lisdexamfetamine (Vyvanse) Reference Number: CP.PMN.121 Effective Date: Last Review Date: Line of Business: Medicaid

Highmark BlueShield Billing Highlights

IEHP UM Subcommittee Approved Authorization Guidelines Electroconvulsive Therapy- ECT

Medical Necessity Criteria 2017

INTERQUAL BEHAVIORAL HEALTH CRITERIA GERIATRIC PSYCHIATRY REVIEW PROCESS

Early and Periodic Screening, Diagnosis and Treatment (EPSDT)

Eligibility Criteria for Children with ASD

ProviderNews FEBRUARY

Education Options for Children with Autism

DOCTOR/PHYSICIAN S CERTIFICATE OF MEDICAL EXAMINATION. In the Matter of the Guardianship of an Alleged Incapacitated Person

Virginia Medicaid Peer Support Services UM Guideline

CLINICAL MEDICAL POLICY

Community Services - Eligibility

Behavioral Health Providers: Facility/Ancillary Application Addendum

MEDICAL POLICY: Telehealth Services

The mission of Imagine! is to create and offer innovative supports to people of all ages with cognitive, developmental, physical, and health related

How to Become (and Remain) an Aerospace Neuropsychologist who Performs Assessments for the FAA

Pre-Employment Psychological Evaluation Guidelines

Evaluating Elements of Scopes of Practice in the Military Health System

Transcription:

Page 1 of 5 SECTION: Medical SUBJECT: Neuropsychological and Psychological Testing DATE OF ORIGIN: 2/13/13 REVIEW DATES: 7/17/15 EFFECTIVE DATE: 12/15/16 APPROVED BY: EXECUTIVE DIRECTOR MEDICAL DIRECTOR I. PURPOSE: To provide guidance for authorization of neuropsychological and psychological testing. II. DEFINITIONS: Neuropsychological Testing: Neuropsychological conditions affect the central nervous system. Services for these conditions include diagnostic testing, pharmacological treatments, medical management, and behavioral health services. Referrals for neuropsychological testing are made by licensed physicians (unless otherwise specified below). The most common reason for a referral is for diagnostic and treatment planning purposes when a central nervous system disorder is suspected and where there are suspected neuro-psychological impairments. The purpose of a neuropsychological assessment is to detect the presence or absence of brain dysfunction by measuring various components of a patient s cognitive function. Neuropsychological testing and evaluation may be considered a useful diagnostic option when indicated for certain individuals who meet medical necessity criteria. Psychological Testing: Psychological testing involves the culturally and linguistically competent administration and interpretation of standardized tests to assess an individual s psychological or cognitive functioning. Referrals for psychological testing may be made for a second opinion for treatment failures and/or cases that are difficult to diagnose. Psychological testing may include one or more tests given to aid in the evaluation of an individual with emotional, psychiatric, neuropsychiatric, personality illness(es) or developmental delays. III. COVERED SERVICES: A. Medical Necessity Criteria The following are required to consider administration of psychological and/or

Page 2 of 5 neuropsychological testing in patients 18 years and older with a severe mental illness or intellectual/developmental disability. 1. Network180 considers neuropsychological testing medically necessary for diagnostic assessment essential to the development of a treatment plan when there has been cognitive impairment due to psychiatric conditions, a significant mental status change not due to a medical disorder that has failed to respond to treatment or a significant behavioral change. An example of a situation when neuropsychological testing may be medically necessary would be for a differential diagnosis between psychogenic and neurogenic syndromes. 2. Network180 considers neuropsychological testing and psychological testing medically necessary when needed to enhance psychiatric or psychotherapeutic treatment outcomes after detailed diagnostic evaluation if/when: a) The individual has pursued authorization and coverage for this service from their qualified health plan or commercial insurance and has received notice of denial of coverage. b) Assistance is needed in the differential diagnosis of a mental disorder or neurological disorder as determined by a licensed physician in consultation with a licensed (LP or LLP) psychologist when the individual s history and symptomatology are not readily attributable to a particular psychiatric diagnosis and the questions to be answered by testing could not be resolved by a psychiatric/diagnostic interview, observation in therapy or an assessment for level of care at a mental health or substance abuse facility; or c) Testing is needed to determine and/or to recommend the most effective treatment after the individual has been tried on various medications and/or psychotherapy and has not progressed in treatment and continues to be symptomatic. d) If applicable, the assigned psychiatrist concurs with the need to obtain neuropsychological or psychological testing. e) No valid existing neuropsychological or psychological testing is available. f) Prior authorization and approval is required from Network180 for an approved Network180 provider. g) The individual s clinical record must indicate the name of the person that administered the tests, the results of the tests, the actual tests administered and any recommendations. The protocols for testing must be available for review. This service includes pre-testing interviews and post-test interpretive activities. B. Medical Necessity Criteria: The following are required to consider administration of psychological and/or neuropsychological testing in patients below the age of 18 years with serious emotional disturbance and/or intellectual/developmental disability. 1. Network180 considers neuropsychological testing medically necessary for diagnostic assessment essential to the development of a treatment plan when there has been cognitive impairment due to psychiatric conditions, a significant mental status change not due to a medical disorder that has failed to respond to treatment, a significant behavioral change or injuries or illnesses that occur during pregnancy or early infancy. An example of a situation when neuropsychological testing may

Page 3 of 5 be medically necessary would be for a differential diagnosis between psychogenic and neurogenic syndromes. 2. Network180 considers neuropsychological testing and psychological testing medically necessary when needed to enhance psychiatric or psychotherapeutic treatment outcomes after detailed diagnostic evaluation if/when: a) The individual has pursued authorization and coverage for this service from their qualified health plan or commercial insurance and has received notice of denial of coverage. b) Assistance is needed in the differential diagnosis of a mental disorder or neurological disorder when the member s history and symptomatology are not readily attributable to a particular psychiatric diagnosis and the questions to be answered by testing could not be resolved by a psychiatric/diagnostic interview, observation in therapy or an assessment for level of care at a mental health or substance abuse facility; or c) Testing is needed to determine and/or to recommend the most effective treatment after the individual has been tried on various medications and/or psychotherapy and has not progressed in treatment and continues to be symptomatic. d) If applicable, the assigned psychiatrist concurs with the need to obtain neuropsychological or psychological testing. e) Valid and existing neuropsychological or psychological test results are not available. f) Prior authorization and approval is required from Network180. i. For individuals authorized for Network180 services, prior authorization and approval for psychological testing is required from Network180. A formal written request for authorization including clinical documentation to support medical necessity criteria is submitted to Network180 by the individual s assigned case manager or supports coordinator for review and determination. Network180 may require evidence of a licensed physician referral for services to verify medical necessity criteria. ii. A referral and/or prescription from a licensed physician is required for psychological and/or neuropsychological testing for individuals not currently authorized for Network180 services. g) The individual s clinical record must indicate the name of the person who administered the tests, the results of the tests, the actual tests administered, and any recommendations. The protocols for testing must be available for review. This service includes pre-testing interviews and post-test interpretive activities. 3. The purpose of the Autism Benefit is to provide for the coverage of Behavioral Health Treatment (BHT) services, including Applied Behavioral Analysis (ABA), for children under 21 years of age with Autism Spectrum Disorders (ASD). The benefit allows neuropsychological testing when a qualified licensed practitioner feels it is necessary in order to determine a diagnosis and medically necessary service recommendations. A review for medical necessity of neuropsychological testing is not required prior to completion of testing.

Page 4 of 5 C. Neuropsychological and psychological testing and evaluation is considered NOT medically necessary for: 1. Pre-surgical clearance. 2. Uncomplicated cases of attention deficit disorder with/without hyperactivity [neuropsychological testing may be considered medically necessary for neurologically complicated cases of ADD/ADHD (e.g., seizures). 3. Diagnosis and management of persons with chronic fatigue syndrome (psychological testing may be medically necessary to differentiate chronic fatigue syndrome from psychiatric diagnoses when criteria for psychological testing are met). 4. Diagnosis and management of persons with delirium or other neurocognitive disorders. 5. Individuals actively abusing substances, having acute withdrawal symptoms or recently entered recovery as test results may be invalid. 6. Education testing this testing is provided by school systems under applicable state and federal rules. In addition, neuropsychological and psychological testing for educational reasons is not considered treatment of disease. 7. Employment, disability qualification, guardianship evaluation or legal/court related purpose is not covered as it is not considered treatment of disease. 8. Routine batteries of psychological tests given at psychiatric inpatient admission or continued stay. D. Typical Utilization Pattern and Associated Outcomes 1. Identification of a plan to improve the health and safety of the individual through differential diagnosis, accommodation of intellectual capacities, and/or investigation of clinical indicators necessary to support the individual/guardian s desired future. 2. Scoring of psychological testing, report writing, and sessions to review test results are considered integral to the testing and are not eligible for separate reimbursement. IV. MEDICAL NECESSITY REVIEW: Required Not Required Not Applicable V. CODING INFORMATION: ICD-9 Codes that may support medical necessity 96101 Psychological Testing 96102 Psychological Testing by Technician 96118 Neuropsychological Testing 96119 Neuropsychological Testing by Technician

Page 5 of 5 VI. REFERENCES: Michigan Department of Health and Human Services (MDHHS); Medicaid Provider Manual Centers for Medicare and Medicaid Services (CMS); Standards and Criteria for Utilization Management A Guide to Psychology and its Practice, Psychological Testing, Retrieved on 7/31/2012 from: http://www.guidetopsychology.com/testing.htm American Academy of Pediatrics. Clinical Practice Guideline: Treatment of the Schoolaged Child with Attention-Deficit/Hyperactivity Disorder, Pediatrics, 1033-1044, Vol. 108, No. 4, Oct 2001. Retrieved on 7/31/2012 from: http://aappolicy.aappublications.org/cgi/content/full/pediatricts;108/4/1033 Frances, Allen, Pincus, Harold, and First, Michael. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association, 1994. Hart, Anita and Hopkins, Catherine. International Classification of Diseases 9th Revision Clinical Modification. USA: Ingenix, 2006. National Academy of Neuropsychology, Neuropsychological Evaluation. Retrieved on 10/19/06 from: http://www.nanonline.org/downloads/paio/paioneurobrochure.pdf VII. ATTACHMENT: Authorization Request Form for Neuropsychological and Psychological Testing